These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2170973)

  • 1. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
    Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
    Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A gene expression in non-small cell lung carcinomas.
    Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
    J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms.
    Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW
    Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in non-small cell lung carcinomas.
    Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
    In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
    Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
    Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
    Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
    Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
    Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
    Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neuroendocrine markers in non-small cell lung cancer.
    Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
    APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin and neurofilament in lung carcinomas.
    van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
    Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cell carcinoma of the lung--ultrastructural and immunohistochemical studies.
    Kodama T; Shimosato Y; Koide T; Watanabe S; Teshima S
    Jpn J Clin Oncol; 1985 Jun; 15(2):431-41. PubMed ID: 2410641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
    Ouyang N; Chen G; Ding J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
    Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
    J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine structures in normal and diseased human lung.
    Mosca L; Ceresoli A; Anzanello E; Mauri F; Mariscotti C; Timossi R; Barbareschi M; Mezzetti M
    Appl Pathol; 1986; 4(3):147-61. PubMed ID: 3036186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal neuroendocrine differentiation in non-small cell carcinoma is not predicted by pre-operative routine investigation.
    Wallace WA
    Eur J Surg Oncol; 2002 Feb; 28(1):63-6. PubMed ID: 11869016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
    Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
    Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.